Page 2 - Douglasa Treco News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Douglasa treco. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Douglasa Treco Today - Breaking & Trending Today

Inozyme Pharma, Inc. (NASDAQ:INZY) CEO Sells $52,209.62 in Stock

Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) CEO Douglas A. Treco sold 7,523 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $6.94, for a total value of $52,209.62. Following the completion of the sale, the chief executive officer now owns 20,665 […] ....

Inozyme Pharma , Douglasa Treco , Inozyme Pharma Company Profile , Inozyme Pharma Inc , Securities Exchange Commission , Eventide Asset Management , Blackrock Inc , Blue Owl Capital Holdings , Get Free Report , Exchange Commission , Asset Management , Capital Partners , Inozyme Pharma Daily , Nasdaq Inzy , Insider Trading , Nsider Trades ,

Inozyme Pharma, Inc. (NASDAQ:INZY) CEO Douglas A. Treco Sells 7,523 Shares

Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) CEO Douglas A. Treco sold 7,523 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $6.94, for a total value of $52,209.62. Following the completion of the sale, the chief executive officer now […] ....

Douglasa Treco , Inozyme Pharma , Inozyme Pharma Inc , Inozyme Pharma Company Profile , Tower Research Capital , Renaissance Technologies , Get Free Report , Research Capital , Sigma Investments , Inozyme Pharma Daily , Nasdaq Inzy , Insider Trading , Nsider Trades ,

Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights

– Topline data from ongoing Phase 1/2 trials of INZ-701 in adults with ABCC6 Deficiency and ENPP1 Deficiency expected in early April –– Phase 1 tr. ....

United States , Douglasa Treco , Stefan Riley , Christine Obrien , Inozyme Pharma , Matt Pera , Sagar Nigwekar , European Calcified Tissue Society Congress , Corporate Communications , Exchange Commission , American Society Of Nephrology , Company Or Inozyme , Kidney Research Center , Inozyme Pharma Inc , Development Rd Expenses , Patient Registry , Christineo Brien , Hemodialysis Now Underway , American Society , Kidney Week , Massachusetts General , Early April , Year Ended December , Financial Guidance , Private Securities Litigation Reform Act , Annual Report ,

State Of The Orphan Space

State Of The Orphan Space
lifescienceleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lifescienceleader.com Daily Mail and Mail on Sunday newspapers.

United States , Douglas Treco , Wayne Koberstein , Douglasa Treco , Executive Editor , Life Science Leader , Treco Headshot , Orphan Drug Act , Gaucher Disease ,

Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights

– Patient recruitment underway in ENERGY-3 Pivotal Trial of INZ-701 in pediatric patients with ENPP1 Deficiency; topline data expected mid-2025 – ....

United States , Stefan Riley , Douglasa Treco , Inozyme Pharma , Matt Pera , Pamerican Society For Bone , Drug Administration , Inozyme Pharma Inc , Development Rd Expenses , American Society For Nephrology , Paediatric Committee Of The European Medicines Agency , Mineral Research , Corporate Communications , American Society Of Nephrology Kidney Week , Exchange Commission , American Society , Nephrology Kidney Week , Pediatric Patients , Global Impression , England Generation , Generalized Arterial Calcification , Genomics England , Generation Study , Kidney Week , Radiographic Global Impression , Rickets Severity Score ,